Australia markets closed

Comera Life Sciences Holdings, Inc. (CMRA)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0292-0.0015 (-4.72%)
At close: 09:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0307
Open0.0292
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0292 - 0.0292
52-week range0.0210 - 0.7390
Volume399
Avg. volume11,204
Market cap899,080
Beta (5Y monthly)0.24
PE ratio (TTM)N/A
EPS (TTM)-0.2200
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option

    WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a proprietary drug-delivery technology to improve patient access, safety, and convenience, today announced the closing of a bridge financing with a syndicate of investors. Following the closing, the investors exercised a purchase option to acquire all of the outstanding common stock of the Company not already held by the investors to t

  • GlobeNewswire

    Comera Life Sciences Announces Process Exploring Strategic Alternatives

    WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced that it has initiated a process to explore strategic alternatives to maximize shareholder value. As part of its process, Comera is exploring the potential for an acquisition, company sale, merger, divestiture of assets, licensing,

  • GlobeNewswire

    Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

    Dorothy Clarke Dorothy Clarke WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced it appointed Dorothy Clarke to its board of directors. “Dorothy’s extensive experience will help Comera continue to deliver on its mission of delivering transformative solutions that have the potential to revolutionize the way